Skip to content

David Erritzøe

Imperial College London

2 papers in the Anchorcite directory, published between 2016 and 2021, cited 3,119 times in total.

ORCID profile

Research topics

Frequent co-authors

  • Robin Lester Carhart-Harris · 2 papers
  • David Nutt · 2 papers
  • Mark Bolstridge · 1 paper
  • James Rucker · 1 paper
  • Camilla Day · 1 paper
  • Mendel Kaelen · 1 paper
  • Michael Bloomfield · 1 paper
  • Ben Forbes · 1 paper

Papers

  1. Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility studyThe Lancet Psychiatry · 2016 · 1,643 citations

    BACKGROUND: Psilocybin is a serotonin receptor agonist that occurs naturally in some mushroom species. Recent studies have assessed the therapeutic potential of psilocybin for various conditions, including end-of-life anxiety, obsessive-compulsive disorder, and smoking and alcohol dependence, with promising preliminary results.…

  2. Trial of Psilocybin versus Escitalopram for DepressionNew England Journal of Medicine · 2021 · 1,476 citations

    BACKGROUND: Psilocybin may have antidepressant properties, but direct comparisons between psilocybin and established treatments for depression are lacking. METHODS: In a phase 2, double-blind, randomized, controlled trial involving patients with long-standing, moderate-to-severe major depressive disorder, we compared psilocybin with escitalopram,…

Metadata from OpenAlex (CC0).